
Bijal Shah, MD, Moffitt Cancer Center
Advertisement
Articles by Bijal Shah, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
An Introduction to Mantle Cell Lymphoma & KTE-X19June 24th 2020
Future Directions in Mantle Cell LymphomaJune 24th 2020
A Look at ZUMA-2 TrialJune 24th 2020
Bruton Tyrosine Kinase InhibitorsJune 24th 2020
ASCO 2020: ZUMA-2 UpdateJune 24th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC
2
Ivonescimab Plus Chemotherapy Sustains OS Benefit Across Western and Asian Patients in Pretreated EGFR-Mutated NSCLC
3
NMPA Accepts Toripalimab Plus Chemotherapy Application for Expanded Stage II-III NSCLC Use
4
Dr Patel on the Unmet Need in EGFR+ Transformed Small Cell Lung Cancer
5




